Sino-U.S. Investment Vehicle To Bring U.S. Medicines Into Chinese Pharmaceutical Market

In the U.S. the pharmaceutical industry has proprietary technology, but China has enough financial resources and a huge domestic market. Therefore an opportunity presents itself for those who can bridge these two markets. Michelle Jarboe McFee has an interesting article about a partnership between Newsummit Pharmaceutical Group, a biomedical company in Shanghai and Cleveland Bio […]

Ernst & Young Report: The Benefits of software IPR protection in China

Unlicensed software should be cleaned upPhoto: Danny Friedmann Not only the Business Software Association writes interesting reports about intellectual property in China in relation to software. Ernst & Young who are in the assurance, tax, transactions and advisory business, just published a report worth reading called:  The Benefits of software IPR protection in China (28 pages […]